MedPath

Elite Sport and Development of Asthma

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: Placebo
Registration Number
NCT00262587
Lead Sponsor
Bispebjerg Hospital
Brief Summary

International studies have shown that elite athletes have a high prevalence of respiratory symptoms and asthma as compared to normal subjects. It is unclear whether the increased prevalence of asthma in elite athletes reflects "traditional asthma" or whether it is a special form of "sports asthma". The treatment of elite athletes with asthma seems to vary widely, and only a few studies have focused on the treatment of elite athletes with asthma. Further knowledge of the pathogenesis of sports asthma would lead to a greater understanding and better treatment of the condition. This study will investigate the type of airway inflammation in elite athletes and examine the effect of treatment with inhaled steroids in combination with long-acting beta-agonists versus placebo in the same group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Elite athletes
  • Informed consent
  • Doctor diagnosed asthma
Exclusion Criteria
  • Current smoker or more than 10 pack-years
  • Pregnancy, breast feeding or planning pregnancy during the study.
  • ICS within the last 4 weeks prior to visit 1.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboPlacebo inhaler (sugar powder)
SeretideSeretideSeretide inhaler
Primary Outcome Measures
NameTimeMethod
Eucapnic voluntary hyperventilation (EVH)End of study
Exhaled Nitric OxideEnd of study
Secondary Outcome Measures
NameTimeMethod
Respiratory symptomsEnd of study
Lung functionEnd of study

Trial Locations

Locations (1)

Respiratory and Allergy Research Unit, Department of Respiratory Medicine, Bispebjerg Hospital

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath